global glp-1 market size 2025 Receptor Agonist Size, Share GLP-1 Receptor Agonist Market Size

typically 13 times per week Possible Side Effects Nausea (especially with injections) Flushing or headache Mild blood pressure changes Side effects are usually dose-dependent and can often be minimized with proper titration

The active ingredient is identical to the branded drug, but a compounded product is not FDA-approved

GLP-3 RT is a next-generation triple hormone agonist hitting the GLP-1, GIP, and glucagon receptors at once researched as one of the most powerful compounds yet studied for weight loss and metabolic health

Wiley Interdiscip Rev Cogn Sci 2017;8:e1427

People who are pregnant or trying to conceive should not take GLP-1 medications